newsfilter
← Latest News
Business Wire·

Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance

3Q 2026 operating revenue of $50.4 billion, up 0.7% from 3Q 2025 3Q 2026 diluted EPS1 of $6.27 and adjusted diluted EPS2 of $6.99; results reflect improved operating performance and a net non-operating benefit of